Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL042125-02
Application #
3360187
Study Section
(SRC)
Project Start
1988-09-30
Project End
1993-09-29
Budget Start
1989-09-30
Budget End
1990-09-29
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
School of Medicine & Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Spiga, M G; Weidner, D A; Trentesaux, C et al. (1999) Inhibition of beta-globin gene expression by 3'-azido-3'-deoxythymidine in human erythroid progenitor cells. Antiviral Res 44:167-77
Pan-Zhou, X R; Cretton-Scott, E; Zhou, X J et al. (1998) Role of human liver P450s and cytochrome b5 in the reductive metabolism of 3'-azido-3'-deoxythymidine (AZT) to 3'-amino-3'-deoxythymidine. Biochem Pharmacol 55:757-66
Koudriakova, T; Manouilov, K K; Shanmuganathan, K et al. (1996) In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI. J Med Chem 39:4676-81
Fowler, D A; Rosenthal, G J; Sommadossi, J P (1996) Effect of recombinant human hemoglobin on human bone marrow progenitor cells: protection and reversal of 3'-azido-3'-deoxythymidine-induced toxicity. Toxicol Lett 85:55-62
Kotra, L P; Manouilov, K K; Cretton-Scott, E et al. (1996) Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathway. J Med Chem 39:5202-7
Fowler, D A; Xie, M Y; Sommadossi, J P (1996) Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells. Antimicrob Agents Chemother 40:191-5
Faraj, A; Schinazi, R F; Xie, M Y et al. (1996) Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells. Antiviral Res 29:261-7
Cui, L; Schinazi, R F; Gosselin, G et al. (1996) Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity. Biochem Pharmacol 52:1577-84
Sommadossi, J P (1995) Comparison of metabolism and in vitro antiviral activity of stavudine versus other 2',3'-dideoxynucleoside analogues. J Infect Dis 171 Suppl 2:S88-92
Sommadossi, J P; Cretton, E M; Kidd, L B et al. (1995) Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy. Cancer Chemother Pharmacol 37:14-22

Showing the most recent 10 out of 35 publications